Seroprevalence of RSV antibodies in a contemporary (2022-2023) cohort of adults

Objectives: Respiratory syncytial virus (RSV) infection may cause serious illness and mortality in older adults (≥65 years). This study aimed to assess the seroprevalence of anti-RSV IgG antibodies in adults from a United States cohort and compare antibody levels among individuals with a history of...

Descrición completa

Detalles Bibliográficos

Principais autores:	Lara I. Teodoro, Inna G. Ovsyannikova, Diane E. Grill, Gregory A. Poland, Richard B. Kennedy
Formato:	Artigo
Idioma:	Inglês
Publicado:	Elsevier 2025-09-01
Series:	International Journal of Infectious Diseases
Assuntos:	RSV Respiratory syncytial virus Seroprevalence Prevalence Disease Human
Acceso en liña:	http://www.sciencedirect.com/science/article/pii/S1201971225001882
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!